Research study Program year 2022 Source: CMS Open Payments

AMG 407 (OTEZLA) - Ph 3 COVID Consortium Study

Research payments

$3,576,877

105 payments

Through program year 2022, $3,576,877 in research payments was reported against AMG 407 (OTEZLA) - Ph 3 COVID Consortium Study, across 105 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$51,378	5
2021	Research	$3,520,593	79
2020	Research	$4,906	21

Breakdown

Who paid Research payments · program years 2020–2022

Amgen Inc. $3,576,877 105 payments

Who received the money Research payments · program years 2020–2022

National Institute Of Clinical Research Organisation paid for research $869,286 4 payments
CardioVoyage, LLC Organisation paid for research $701,362 2 payments
Sarah Cannon Research Institute, LLC Organisation paid for research $538,854 7 payments
Great Lakes Clinical Trials LLC Organisation paid for research $527,903 1 payment
Pinnacle Research Group Organisation paid for research $193,347 3 payments
Multicare Health System Organisation paid for research $173,118 1 payment
The University Of Texas Health Science Center At Houston Organisation paid for research $139,207 1 payment
University of Florida Organisation paid for research $131,277 5 payments
The Regents of The University of California Organisation paid for research $64,193 2 payments
Wayne State University Organisation paid for research $41,154 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.